BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Verona Pharma Reports First Quarter 2022 Financial Results and Provides Corporate Update

  Verona Pharma plc, a clinical-stage biopharmaceutical company focused on respiratory diseases, announces its financial results for the three months ended March 31, 2022, and provides a corporate update.

  May 3, 2022

   · 

  13 min read
• Hemispherian raises seed funding for novel cancer therapeutics

  Hemispherian AS, a Norwegian preclinical pharmaceutical company focused on small molecule cancer therapeutics targeting the DNA damage response, is delighted to announce the closure of its successful seed financing.

  May 3, 2022

   · 

  2 min read
• Business

  Catalent, Inc. Reports Third Quarter Fiscal 2022 Results

  Catalent, Inc. today announced financial results for the third quarter of fiscal 2022, which ended March 31, 2022.

  May 3, 2022

   · 

  26 min read
• Business

  Agile Therapeutics to Report First Quarter 2022 Financial Results and Provide Business Update on Thursday, May 12, 2022

  Agile Therapeutics, Inc. today announced it will report first quarter 2022 financial results after the market close on Thursday, May 12, 2022.

  May 3, 2022

   · 

  1 min read
• Genetown

  Relay Therapeutics to Participate in Fireside Chat at Bank of America Securities 2022 Healthcare Conference

  Relay Therapeutics, Inc. is scheduled to participate in a fireside chat at the Bank of America Securities 2022 Healthcare Conference on Tuesday, May 10, 2022, at 3:20 p.m. PT in Las Vegas, NV.

  May 3, 2022

   · 

  1 min read
• Aptose to Present at 2022 RBC Capital Markets Global Healthcare Conference

  Aptose Biosciences Inc. today announced that Dr. William G. Rice, Chairman, President and CEO of Aptose, will participate in the RBC Capital Markets Global Healthcare Conference.

  May 3, 2022

   · 

  1 min read
• Global Microalbuminuria Market: Growth Opportunity and Current Trends in the Industry [2020-2030]

  Microalbuminuria is a condition that affects the kidney and restricts in retaining serum albumin, which is considered as a vital factor for the kidney to maintain its overall health of the body.

  May 3, 2022

   · 

  6 min read
• Laboratory Shakers Market: Increase in the Inclination toward Automation to Drive the Market

  Albany NY, United States: A laboratory equipment used to mix, agitate, or blend substances in a tube or flask by shaking them is known as laboratory shaker.

  May 3, 2022

   · 

  5 min read
• Business

  Innate Pharma Announces Conference Call and Webcast for Q1 2022 Business Update

  Innate Pharma SA, announced that the Company will hold a conference call on Tuesday, May 10, 2022 at 2 p.m. CEST / 8 a.m. EDT, to give an update on business progress during the first quarter of 2022.

  May 3, 2022

   · 

  4 min read
• Business

  Invitation to presentation of Isofol’s report for the first quarter of 2022

  Isofol Medical AB, will publish the company’s results for the first quarter of 2022 on Thursday, May 12, 2022.

  May 3, 2022

   · 

  2 min read